2022
DOI: 10.1016/j.transproceed.2022.03.036
|View full text |Cite
|
Sign up to set email alerts
|

Hepatorenal Syndrome and Other Post–Liver Transplantation Complications: Case Studies and Literature Review

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
2
0
1

Year Published

2022
2022
2023
2023

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 28 publications
0
2
0
1
Order By: Relevance
“…However, long-term improvements in LTx procedures and patient outcomes have been hampered by the cumulative toxicity of maintenance IS therapy (57). FK506, for instance, was confirmed to be an IS in early studies and is currently the most commonly used drug in the clinic for acute tolerance induction after LTx (58); however, it can cause infection, nephrotoxicity, and incomplete preservation of graft function during tolerance induction (59). Therefore, novel immunosuppressive strategies for active liver tolerance induction and long-term good prognosis are urgently In the present study, we extensively investigated the effects of FK506 therapy on acute tolerance induction, functional recovery, and renal injury protection by comparing them with the effects of HGF from a commonly clinically used HGF-promoting drug (cHGF) in a rat allo-OLT model to assess the clinical relevance of HGF as a novel tolerance inducer.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…However, long-term improvements in LTx procedures and patient outcomes have been hampered by the cumulative toxicity of maintenance IS therapy (57). FK506, for instance, was confirmed to be an IS in early studies and is currently the most commonly used drug in the clinic for acute tolerance induction after LTx (58); however, it can cause infection, nephrotoxicity, and incomplete preservation of graft function during tolerance induction (59). Therefore, novel immunosuppressive strategies for active liver tolerance induction and long-term good prognosis are urgently In the present study, we extensively investigated the effects of FK506 therapy on acute tolerance induction, functional recovery, and renal injury protection by comparing them with the effects of HGF from a commonly clinically used HGF-promoting drug (cHGF) in a rat allo-OLT model to assess the clinical relevance of HGF as a novel tolerance inducer.…”
Section: Discussionmentioning
confidence: 99%
“…However, long-term improvements in LTx procedures and patient outcomes have been hampered by the cumulative toxicity of maintenance IS therapy ( 57 ). FK506, for instance, was confirmed to be an IS in early studies and is currently the most commonly used drug in the clinic for acute tolerance induction after LTx ( 58 ); however, it can cause infection, nephrotoxicity, and incomplete preservation of graft function during tolerance induction ( 59 ). Therefore, novel immunosuppressive strategies for active liver tolerance induction and long-term good prognosis are urgently needed.…”
Section: Discussionmentioning
confidence: 99%
“…Autorzy badania podkreślają istotność odpowiedniego doboru osób mających tworzyć profesjonalne cyfrowe narzędzia dydaktyczne oraz podkreślają fakt, iż pomimo rosnącego zainteresowania tym sposobem przekazywania informacji koniecznym staje się przeprowadzenie szerszych badań i analiz nad zapotrzebowaniem na mobilne aplikacje medyczne 5 . Jak wykazano w badaniu autorów z 2022 r., w zakresie społecznej edukacji transplantologicznej duże zapotrzebowanie na podręczne źródła informacji wymaga rozwoju nowoczesnych metod edukacji medycznej i społecznej, szczególnie skutecznych i efektywnych w młodych grupach wiekowych 6 . Tworzenie aplikacji do szkolenia w zakresie nauk medycznych może również stać się kluczowym elementem ciągłej edukacji medycznej przez całe życie 5 .…”
Section: Wirtualna Rzeczywistość a Edukacjaunclassified